Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Beckman Coulter Adopts Verification System

By Labmedica staff writers
Posted on 21 Jul 2006
The Artel MVS (multichannel verification system), developed by Artel (Westbrook, Maine, USA), has been adopted by Beckman Coulter (Fullerton, CA, USA), leading manufacturer of testing instrumentation, in order to verify the accuracy and precision of its automated liquid handling systems used in pharmaceutical and clinical laboratories. More...


A future option to the company's Biomek customers, the MVS will provide documentation about system performance, aiding labs to meet compliance and regulatory requirements. The MVS will be part of the company's Field Service Operational Qualification Program.

Because Biomek customers quickly generate data used in critical assays and due to increasing regulatory pressure governing process controls, Beckman Coulter wanted a more convenient method to measure instrument performance. Upgrading its Field Service Operational Qualification Program technology with the MVS, a rapid and traceable system, allows Beckman Coulter to easily meet customer demands for documented validation.

Artel's MVS allows us to rapidly assess the performance of our instruments in the field and provide documented, traceable data, notes Lisa Knapp, technical services manager for Beckman Coulter. This is especially important for some of our customers operating in regulated environments who need third-party validation of instrumentation and processes.

The MVS is based on proprietary ratiometric photometry, which measures light absorption by two specially formulated dyes in order to verify volume, making it especially effective at low volumes. In addition, the MVS can perform calibration very quickly, and can be applied to Beckman Coulter's full portfolio of Biomek liquid handlers, ranging from one to 384 channels.

The MVS is becoming the tool of choice for laboratory liquid delivery quality assurance, noted Ms. Knapp. We equipped our service representatives with a standard performance measurement tool so they can communicate in the same language with Artel's customers using the MVS on the bench, and this will streamline service visits. Robust and unaffected by environmental conditions, the MVS is portable and user-friendly, facilitating its use by service representatives in the field as well as by end-users for interim checks.



Related Links:
Artel
Beckman Coulter

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.